Description
The Nasiff CardioCard® System represents over three decades of innovation in computerized electrocardiography. As a pioneer in PC-based ECG technology since 1989, Nasiff has developed a comprehensive platform that transforms standard computers into powerful, interpretive cardiac diagnostic workstations . Designed for hospitals, cardiology practices, clinics, and research institutions, the CardioCard system combines medical-grade accuracy with the flexibility and familiarity of PC-based operation.
Unlike traditional standalone ECG machines with limited processing power and proprietary interfaces, the CardioCard system leverages the full capabilities of Windows-based computers. This approach provides healthcare professionals with unlimited patient data storage, seamless Electronic Medical Record (EMR) integration at no additional cost, and the ability to generate customizable digital reports with exceptional clarity . The system’s modular design allows practices to configure a solution that precisely matches their clinical needs—whether for resting ECGs, stress testing, Holter monitoring, or comprehensive vital signs assessment.
A Unified Platform for Complete Cardiac Care
The CardioCard product line offers four specialized configurations, all integrated through the powerful CardioCard System Software:
-
CardioResting™ ECG System: Delivers high-quality 12-lead resting ECGs with simultaneous lead acquisition and automatic interpretation. Ideal for routine examinations, pre-operative assessments, and baseline documentation .
-
CardioStress™ ECG System: Designed for exercise tolerance testing and pharmacological stress studies. Provides stable, artifact-resistant ECG traces even during patient motion, enabling confident detection of exercise-induced ischemia and arrhythmias .
-
CardioHolter™ ECG System: Offers continuous ambulatory monitoring to capture intermittent arrhythmias that standard resting ECGs may miss. Lightweight and patient-friendly, with streamlined software review tools for efficient analysis .
-
CardioCard with NIBP System: Integrates 12-lead ECG with automatic non-invasive blood pressure monitoring, with optional SpO₂ and spirometry capabilities. Provides a comprehensive cardiovascular assessment in a single, streamlined system .
Advanced Auto-Interpretive Analysis
At the heart of the CardioCard system lies a sophisticated auto-diagnostic engine capable of detecting over 200 known cardiac events, injuries, and abnormalities . This interpretive capability was developed through decades of refinement, incorporating hundreds of thousands of real-world ECG tests shared by leading cardiologists worldwide. The system can identify:
-
Atrial fibrillation (AFib) and other arrhythmias
-
Myocardial infarction (heart attack) indicators
-
Ventricular tachycardia and other life-threatening rhythms
-
ST-segment elevation and ischemic changes
-
Bundle branch blocks and conduction abnormalities
-
Conditions related to athletic stress and physical trauma
Unlike emerging AI systems that require extensive training, the Nasiff interpretive engine benefits from decades of clinical validation and refinement by human experts, delivering trusted, actionable interpretations that support confident clinical decision-making .
Seamless EMR Integration and Workflow Efficiency
The CardioCard system includes EMR connectivity as a standard feature—no additional licensing fees, recurring charges, or costly interface modules are required . This out-of-the-box interoperability enables:
-
Immediate and seamless report sharing with existing electronic health records
-
Enhanced documentation accuracy and reduced manual data entry
-
Streamlined patient management across the care continuum
The intuitive point-and-click user interface minimizes the learning curve, allowing physicians and technicians to focus on patient care rather than navigating complex technology . Training materials and comprehensive documentation are included to support rapid implementation and staff proficiency .
Superior Signal Quality and Diagnostic Precision
The CardioCard system preserves the integrity of original cardiac waveform data, avoiding the aggressive filtering that can obscure subtle but clinically significant abnormalities . Key technical specifications include:
-
12-lead simultaneous acquisition with interpretive analysis
-
Sampling rates from 250 to 1000 Hz for detailed waveform capture
-
Frequency response: 0.05-150 Hz standard (higher options available)
-
ECG measurement resolution: 4 ms, 1.22 µV at 10 mm/s gain
-
CMRR: 120 dB for excellent noise rejection
-
Lead-off detection with 100 MΩ impedance
Manual filter adjustment options give physicians control over the diagnostic process, allowing optimization for specific patient populations or clinical scenarios without compromising data clarity .
Portable and Wireless Capabilities
For healthcare providers requiring mobility, the CardioCard Mobileâ„¢ app extends system functionality to iOS devices (iPhone, iPad, and iPod)Â . Using wireless, iOS-compatible CardioCard monitors, clinicians can:
-
Perform full 12-lead ECGs at the point of care
-
View real-time waveforms and identify serious issues immediately
-
Sync data seamlessly with the CardioCard management system on Mac or Windows computers
-
Maintain the same patient database, analysis tools, and reporting capabilities as the desktop system
Comprehensive Support and Value
Every Nasiff CardioCard system includes:
-
Two full years of live company expert support—no outsourced call centers, no tiered support structures
-
Complete training and configuration assistance for smooth adoption
-
Two-year warranty with no hidden service contracts or subscription fees
-
Unlimited patient database with no capacity restrictions
-
All software updates included
Made in the USA, Trusted Worldwide
Nasiff Associates, Inc. is a veteran-owned American medical technology company. All CardioCard systems are FDA-cleared and manufactured in the United States, ensuring compliance with rigorous quality standards . With decades of proven performance in hospitals, clinics, and research institutions worldwide, the Nasiff CardioCard system continues to set the benchmark for reliable, clinically accurate ECG diagnostics.





Reviews
There are no reviews yet.